CoverageForm 410-K10-Q8-K13D13G13F

EXPO · Exponent Inc - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · EXPO

Income Statement

Line itemQ1 '26Q3 '25Q2 '25Q1 '25Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23
Revenue$166.30M$147.12M$141.96M$145.51M$136.28M$140.54M$144.93M-$133.34M$140.22M
Cost of Revenue----------
Gross Profit----------
R&D----------
SG&A$6.20M$7.65M$6.14M$5.01M$5.31M$6.04M$5.64M-$6.02M$6.64M
Total Operating Expenses$124.92M$118.08M$124.78M$101.08M$110.43M$104.79M$114.22M-$99.40M$110.35M
D&A$2.52M$2.53M$2.52M$2.49M$2.39M$2.49M$2.32M-$2.36M$2.19M
Operating Income$41.38M$29.04M$17.18M$44.43M$25.85M$35.74M$30.71M-$33.93M$29.88M
Interest Expense----------
Income Tax$12.77M$10.57M$10.26M$11.11M$9.89M$10.46M$10.28M-$9.48M$10.51M
Net Income$29.57M$28.04M$26.55M$26.65M$26.04M$29.23M$30.14M-$24.54M$25.75M
EPS - Basic$0.59$0.55$0.52$0.52$0.51$0.57$0.59-$0.48$0.50
EPS - Diluted$0.59$0.55$0.52$0.52$0.50$0.57$0.59-$0.48$0.50

Balance Sheet

Line itemQ1 '26Q3 '25Q2 '25Q1 '25Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23
Cash & Equivalents$118.55M$207.38M$231.80M$245.11M$219.71M$203.26M$168.66M$187.15M$137.10M$148.17M
Accounts Receivable$197.34M$182.00M$171.01M$166.79M$168.62M$165.87M$162.88M$167.36M$181.75M$175.83M
Inventory----------
Accounts Payable$6.87M--$5.27M---$4.49M--
Current Assets$340.89M$416.79M$425.65M$432.80M$412.58M$391.33M$352.32M$379.53M$343.32M$344.63M
Total Assets$687.38M$761.45M$759.43M$763.24M$744.07M$709.18M$629.40M$646.78M$602.46M$604.28M
Current Liabilities$142.20M$154.77M$134.97M$130.27M$137.74M$131.82M$114.13M$161.91M$129.66M$124.54M
Long-term Debt----------
Total Liabilities$349.04M$358.59M$331.65M$321.83M$333.79M$315.96M$255.09M$290.69M$248.83M$247.21M
Stockholders' Equity$338.34M$402.86M$427.78M$441.41M$410.27M$393.21M$374.31M$356.08M$353.63M$357.08M
Retained Earnings$682.01M$658.79M$646.04M$635.02M$614.99M$603.37M$588.57M$574.08M$566.52M$555.35M

Cash Flow

Line itemQ1 '26Q3 '25Q2 '25Q1 '25Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23
Operating Cash Flow($975.0K)--$7.27M--$10.43M---
Investing Cash Flow($2.45M)--($1.75M)--($1.48M)---
Financing Cash Flow($99.68M)--($20.05M)--($27.23M)---
CapEx$2.45M--$1.75M--$1.48M---
Free Cash Flow($3.43M)--$5.52M--$8.95M---

Ratios

MetricQ1 '26Q3 '25Q2 '25Q1 '25Q3 '24Q2 '24Q1 '24Q4 '23Q3 '23Q2 '23
Profitability
Gross margin----------
Operating margin24.9%19.7%12.1%30.5%19.0%25.4%21.2%-25.4%21.3%
EBITDA margin26.4%21.5%13.9%32.2%20.7%27.2%22.8%-27.2%22.9%
Net margin17.8%19.1%18.7%18.3%19.1%20.8%20.8%-18.4%18.4%
Free cash flow margin-2.1%--3.8%--6.2%---
FCF / Net income-0.12--0.21--0.30---
R&D / Revenue----------
SG&A / Revenue3.7%5.2%4.3%3.4%3.9%4.3%3.9%-4.5%4.7%
Effective tax rate30.2%27.4%27.9%29.4%27.5%26.3%25.4%-27.9%29.0%
Return on assets4.3%3.7%3.5%3.5%3.5%4.1%4.8%-4.1%4.3%
Return on equity8.7%7.0%6.2%6.0%6.3%7.4%8.1%-6.9%7.2%
Return on invested capital----------
Liquidity
Current ratio2.402.693.153.323.002.973.092.342.652.77
Quick ratio2.402.693.153.323.002.973.092.342.652.77
Cash ratio0.831.341.721.881.601.541.481.161.061.19
Leverage
Debt / Equity----------
Debt / Assets----------
Debt / EBITDA----------
Interest coverage----------
Equity multiplier2.031.891.781.731.811.801.681.821.701.69
Liabilities / Assets0.510.470.440.420.450.450.410.450.410.41
Efficiency
Asset turnover0.240.190.190.190.180.200.23-0.220.23
Inventory turnover----------
Days sales outstanding433d452d440d418d452d431d410d-498d458d
Days inventory outstanding----------
Days payable outstanding----------
Cash conversion cycle----------
Valuation
P / E112.8x122.0x148.3x148.2x226.5x166.9x140.2x-178.3x186.6x
P / B9.9x8.5x9.3x9.0x14.2x12.5x11.4x-12.5x13.5x
P / S20.1x23.3x28.0x27.4x42.9x34.9x29.3x-33.2x34.4x
EV / EBITDA73.3x102.2x189.8x79.6x199.3x122.9x123.6x-118.0x145.8x
Growth
Revenue growth (YoY)14.3%8.0%1.0%0.4%2.2%0.2%3.3%-4.8%7.6%
Revenue CAGR (3y)5.8%5.0%2.9%4.2%5.4%5.4%7.6%-10.6%15.1%
Revenue CAGR (5y)7.4%8.3%9.1%6.6%7.4%5.7%7.9%-6.9%8.0%
Gross profit growth (YoY)----------
Operating income growth (YoY)-6.9%12.3%-51.9%44.7%-23.8%19.6%5.5%--7.8%-34.0%
Net income growth (YoY)11.0%7.7%-9.1%-11.6%6.1%13.5%3.5%-0.4%-0.0%
EPS growth (YoY)13.5%10.0%-8.8%-11.9%4.2%14.0%5.4%-2.1%2.0%
EPS CAGR (3y)1.8%5.4%2.0%-3.6%2.8%5.9%0.6%-12.2%17.3%
EPS CAGR (5y)0.3%10.1%10.9%1.2%6.8%7.9%7.0%-8.4%8.0%
FCF growth (YoY)----38.3%------
FCF CAGR (5y)----------
Book value growth (YoY)-23.4%-1.8%8.8%17.9%16.0%10.1%9.5%11.0%10.6%5.8%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2026-01-02.

Business segments

$582.01M total
Engineering And Other Scientific$493.89M · 84.9%
Environmental And Health$88.12M · 15.1%

Geographic

$582.01M total
US$520.59M · 89.4%
Non Us$61.42M · 10.6%

Peer comparison

Same SIC group: Services-Management Consulting Services

CompanyRevenue (last FY)Net marginROE
HURN$1.70B6.2%19.9%
BAH$11.22B7.6%77.0%
FCN$3.79B7.1%15.6%
G$5.08B10.9%21.7%
BWMN$490.02M2.6%4.9%

Comparing EXPONENT INC against the 5 most active filers in the same SIC group.

Dividends

$1.21/share trailing 12 months · +6.1% YoY

Ex-datePer share
Mar 6, 2026$0.3100
Dec 5, 2025$0.3000
Sep 5, 2025$0.3000
Jun 6, 2025$0.3000
Mar 7, 2025$0.3000
Dec 6, 2024$0.2800
Sep 6, 2024$0.2800
Jun 7, 2024$0.2800
Mar 7, 2024$0.2800
Dec 7, 2023$0.2600
Sep 7, 2023$0.2600
Jun 8, 2023$0.2600
Mar 9, 2023$0.2600
Dec 8, 2022$0.2400
Sep 8, 2022$0.2400
Jun 9, 2022$0.2400
Mar 10, 2022$0.2400
Dec 2, 2021$0.2000
Sep 9, 2021$0.2000
Jun 10, 2021$0.2000
Mar 11, 2021$0.2000
Dec 3, 2020$0.1900
Sep 10, 2020$0.1900
Jun 11, 2020$0.1900